Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
5 Patents
#182 in Waltham, MA
#2,897 in Massachusetts
#51,708 in US
Biogen Idec Hemophilia Inc.
Forward Citations = 77
18 inventors:
Waltham, MA, United States of America
Biogen Idec Hemophilia Inc.
Calculating rank
% Expired Patents = 40.0
EPO Patents = 2
Forward Citations = 77
Loading Chart...
Loading Chart...
18 inventors (with patents filed for the assignee):
Robert T Peters (3 out of 63 patents)
Alan J Bitonti (3 out of 43 patents)
Adam Robert Mezo (3 out of 24 patents)
4. Daniel S Rivera (2 out of 11 patents)
5. Susan C Low (2 out of 21 patents)
6. Kevin McDonnell (2 out of 32 patents)
7. Haiyan Jiang (1 out of 30 patents)
8. Jurg Sommer (1 out of 10 patents)
9. Glenn Pierce (1 out of 25 patents)
10. Jennifer A Dumont (1 out of 18 patents)
11. Alvin Luk (1 out of 6 patents)
12. Byron McKinney (1 out of 6 patents)
13. Matt Ottmer (1 out of 6 patents)
14. Karen Nugent (1 out of 6 patents)
15. Lian Li (1 out of 6 patents)
5 patents:
Company Overview
Biogen Idec Hemophilia Inc. is a leading biotechnology company specializing in the research, development, and commercialization of therapies for hemophilia. With a strong focus on innovation and improving patient outcomes, the company is dedicated to advancing the field of hemophilia treatment. Through groundbreaking research and partnerships with healthcare providers, Biogen Idec Hemophilia Inc. is committed to making a positive impact on the lives of patients with hemophilia.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biogen Idec Hemophilia Inc.. Retrieved from https://idiyas.com/company/biogen-idec-hemophilia
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]